首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1705690

注射劑市場按分子類型、給藥途徑、治療領域、藥物類別、通路和地區分類

Injectable Drugs Market, By Molecule Type, By Route of Administration, By Therapeutic Area, By Drug Class, By Distribution Channel, By Geography

出版日期: 2025年02月20日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球注射藥物市場規模估計為 6,140.7 億美元，預計到 2032 年將達到 13,278 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.7%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	6140.7億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	7.70%	2032年價值預測	13.278億美元

數字。 2025年注射藥物市場佔有率（按地區分類）

注射藥物是直接注射到體內的藥物，主要透過靜脈、肌肉或組織。由於它將藥物直接輸送到血液中，因此在各種重症加護程序中它比其他藥物傳輸方法更受歡迎。藥物傳遞技術的進步促進了新型注射劑型的開發，從而提高了活性藥物成分的穩定性、溶解度和生物有效性。慢性病盛行率的上升、對生技藥品和標靶藥物治療的日益關注以及對自我注射劑的需求的不斷成長可能會推動市場成長。

市場動態：

全球注射劑市場的成長受到癌症、糖尿病和自體免疫疾病等慢性疾病盛行率上升的推動。根據世界衛生組織估計，慢性病佔全球死亡人數的60%以上。此外，生技藥品和標靶藥物療法在癌症和自體免疫疾病治療的快速應用也推動了市場的成長。然而，注射劑研究、開發和製造的高成本可能會給市場相關人員帶來挑戰。此外，注射藥物時針刺傷的風險也可能阻礙其廣泛使用。自我注射劑的需求不斷成長，特別是對於慢性病管理的需求，很可能在不久的將來提供成長機會。

本研究的主要特點

本報告對全球注射劑市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模（以十億美元為單位）和年複合成長率（CAGR%）。

它還強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。

全球注射劑市場的主要企業已根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行了分析。

主要企業包括輝瑞、諾華、賽諾菲、GlaxoSmithKline Plc、吉利德科學和艾伯維。

本報告提供的見解將幫助負責人和企業經營團隊未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球注射劑市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過用於分析全球注射劑市場的各種策略矩陣來促進他們的決策。

Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Sanofi SA
Sun Pharmaceutical Industries Ltd.
AstraZeneca Plc
Merck & Co., Inc.
Viatris+Mylan NV
Cipla Inc.
Dr Reddy's Laboratories Ltd.
Samsung Biologics
Abbott Laboratories
Amgen Incorporated
Baxter International Incorporated
Becton Dickinson and Company
Bristol-Myers Squibb Company
GlaxoSmithKline Plc
Roche Holding Limited

第 11 章分析師建議

命運之輪
分析師觀點
一致的機會圖

第12章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI5378

Global Injectable Drugs Market is estimated to be valued at USD 614.07 Bn in 2025 and is expected to reach USD 1,032.78 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 614.07 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.70%	2032 Value Projection:	USD 1,032.78 Bn

Figure. Injectable Drugs Market Share (%), By Region 2025

Injectable drugs refer to medications that are administered directly into the body, mostly through veins, muscles or tissues. These are preferred over other drug delivery methods for various critical care therapies, owing to their ability to deliver medications directly into the bloodstream, ensuring rapid onset of action. Advancements in drug delivery technologies have led to development of novel injectable formulations with improved stability, solubility and bioavailability of active pharmaceutical ingredients. Growing prevalence of chronic diseases, rising focus on biologics and targeted drug therapies, and increasing demand for self-administered injectables can drive the market growth.

Market Dynamics:

Global injectable drugs market growth is driven by rising prevalence of chronic diseases such as cancer, diabetes and autoimmune disorders. According to WHO, chronic diseases are estimated to account for over 60% of global deaths. Rapid adoption of biologics and targeted drug therapies for treatment of cancer and autoimmune diseases can also drive the market growth. However, high costs associated with R&D and manufacturing of injectable products can pose challenges for the market players. Risk of needle-stick injuries while administering injectables can also hamper its adoption. Growing demand for self-administered injectables especially for management of chronic diseases can offer growth opportunities in the near future.

Key features of the study:

This report provides in-depth analysis of the global injectable drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global injectable drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Novartis, Sanofi, GlaxoSmithKline, Gilead Sciences and AbbVie

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drugs market

Detailed Segmentation-

By Molecule Type Insights (Revenue, USD Bn, 2020 - 2032)
- Small Molecule
- Large Molecule
By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Intravenous
- Intramuscular
- Subcutaneous
- Others (Intradermal etc.)
By Therapeutic Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Infectious Diseases
- Autoimmune Disorders
- Cardiovascular Diseases
- Endocrinology
- Neurology
- Others (Respiratory, Hematology, etc.)
By Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Monoclonal Antibodies
- Peptides and Proteins
- Small Molecules
- Immunoglobulins
- Hormones
- Others (Vaccines, Biologics, etc.)
By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- AstraZeneca Plc
- Merck & Co., Inc.
- Viatris + Mylan N.V
- Cipla Inc.
- Dr Reddy's Laboratories Ltd.
- Samsung Biologics
- Abbott Laboratories
- Amgen Incorporated
- Baxter International Incorporated
- Becton Dickinson and Company
- Bristol-Myers Squibb Company
- GlaxoSmithKline Plc
- Roche Holding Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Injectable Drugs Market, By Molecule Type
- Global Injectable Drugs Market, By Route of Administration
- Global Injectable Drugs Market, By Therapeutic Area
- Global Injectable Drugs Market, By Drug Class
- Global Injectable Drugs Market, By Distribution Channel
- Global Injectable Drugs Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Injectable Drugs Market, By Molecule Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Small Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Large Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Injectable Drugs Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Intradermal etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Injectable Drugs Market, By Therapeutic Area, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Autoimmune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Respiratory, Hematology, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Injectable Drugs Market, By Drug Class, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Peptides and Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Small Molecules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Immunoglobulins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Vaccines, Biologics, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Injectable Drugs Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Injectable Drugs Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021- 2032, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country/Sub-region, 2020 - 2032, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd.
AstraZeneca Plc
Merck & Co., Inc.
Viatris + Mylan N.V
Cipla Inc.
Dr Reddy's Laboratories Ltd.
Samsung Biologics
Abbott Laboratories
Amgen Incorporated
Baxter International Incorporated
Becton Dickinson and Company
Bristol-Myers Squibb Company
GlaxoSmithKline Plc
Roche Holding Limited